Stem Cell Therapy Shows Promise for Retinal Degeneration

Retinal pigment epithelial (RPE) cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain, according to pioneers in the field. Two teams of researchers reported preliminary findings from phase 1 and phase 2 trials at the American Academy of Ophthalmology (AAO)